Mark Wood

719 total citations
17 papers, 209 citations indexed

About

Mark Wood is a scholar working on Surgery, Hematology and Rheumatology. According to data from OpenAlex, Mark Wood has authored 17 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Hematology and 4 papers in Rheumatology. Recurrent topics in Mark Wood's work include Kawasaki Disease and Coronary Complications (4 papers), Adolescent and Pediatric Healthcare (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Mark Wood is often cited by papers focused on Kawasaki Disease and Coronary Complications (4 papers), Adolescent and Pediatric Healthcare (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Mark Wood collaborates with scholars based in United Kingdom, Australia and Italy. Mark Wood's co-authors include Richard J. Wakefield, Angelo Ravelli, Paul Emery, Stefano Lanni, Neil McHugh, Clarissa Pilkington, Lucy R. Wedderburn, Stefania Simou, Sarah Tansley and Thomas S. Jacques and has published in prestigious journals such as The Lancet, Emerging infectious diseases and Archives of Disease in Childhood.

In The Last Decade

Mark Wood

14 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Wood United Kingdom 7 75 54 54 40 38 17 209
Rebecca Nicolai Italy 7 73 1.0× 67 1.2× 87 1.6× 41 1.0× 54 1.4× 26 224
S. Sen India 10 52 0.7× 68 1.3× 24 0.4× 36 0.9× 52 1.4× 33 291
Ali Karakuzu Türkiye 8 46 0.6× 84 1.6× 33 0.6× 23 0.6× 44 1.2× 29 236
Sara Taha Egypt 9 44 0.6× 40 0.7× 21 0.4× 44 1.1× 44 1.2× 48 254
Ana Pérez Spain 10 139 1.9× 133 2.5× 39 0.7× 24 0.6× 33 0.9× 25 282
Emel Çalıkoğlu Türkiye 9 42 0.6× 100 1.9× 35 0.6× 26 0.7× 39 1.0× 25 348
Paula Boggio Argentina 10 66 0.9× 127 2.4× 18 0.3× 21 0.5× 16 0.4× 28 297
António Panarra Portugal 6 63 0.8× 145 2.7× 22 0.4× 37 0.9× 24 0.6× 24 260
Nordau Kanigsberg Canada 11 46 0.6× 76 1.4× 12 0.2× 64 1.6× 45 1.2× 28 326
Rohini Samant India 9 17 0.2× 97 1.8× 66 1.2× 31 0.8× 51 1.3× 31 255

Countries citing papers authored by Mark Wood

Since Specialization
Citations

This map shows the geographic impact of Mark Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wood more than expected).

Fields of papers citing papers by Mark Wood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wood. The network helps show where Mark Wood may publish in the future.

Co-authorship network of co-authors of Mark Wood

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wood. A scholar is included among the top collaborators of Mark Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wood. Mark Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Cooray, Samantha, Ying Hong, Charalampia Papadopoulou, et al.. (2020). Anti-tumour necrosis factor treatment for the prevention of ischaemic events in patients with deficiency of adenosine deaminase 2 (DADA2). Lara D. Veeken. 60(9). 4373–4378. 34 indexed citations
3.
Clarke, Katherine, et al.. (2017). Neonatal Behçet's disease. Archives of Disease in Childhood. 102(11). 1062–1062.
4.
Tansley, Sarah, Zoë Betteridge, Stefania Simou, et al.. (2017). Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. The Journal of Rheumatology. 44(4). 488–492. 53 indexed citations
5.
Tansley, Sarah, Zoë Betteridge, Stefania Simou, et al.. (2016). 174 A Diagnostic and Treatment Challenge: The Prevalence and Clinical Associations of Anti-HMG-CoA Reductase Autoantibodies in a Large UK Juvenile-Onset Myositis Cohort. Lara D. Veeken. 55(suppl_1). i132–i133. 2 indexed citations
6.
Amin, Tania, et al.. (2016). Primary hypertrophic osteoarthropathy: ultrasound and MRI findings. Pediatric Radiology. 46(5). 727–730. 7 indexed citations
7.
Abinun, Mario, et al.. (2016). Infection-Related Death among Persons with Refractory Juvenile Idiopathic Arthritis. Emerging infectious diseases. 22(10). 1720–1727. 5 indexed citations
8.
Leone, Valentina & Mark Wood. (2015). Abstracts from the 2014 Annual Conference of the British Society of Paediatric and Adolescent Rheumatology. Lara D. Veeken. 54(suppl_2). ii1–ii1. 3 indexed citations
9.
Lanni, Stefano, et al.. (2012). Towards a role of ultrasound in children with juvenile idiopathic arthritis. Lara D. Veeken. 52(3). 413–420. 40 indexed citations
10.
Wood, Mark, et al.. (2012). The baby with blue fingers: Unusual presentation of Kawasaki Disease. Archives of Disease in Childhood. 97(Suppl 1). A127.1–A127. 1 indexed citations
11.
Wood, Mark, et al.. (2011). Development of a single paediatric infliximab administration guideline. Archives of Disease in Childhood. 96(4). e1–e1. 2 indexed citations
12.
McCrindle, Brian W., Mark Wood, George F. Collins, Brian Wheatley, & R D Rowe. (1996). An increased incidence of total anomalous pulmonary venous drainage among aboriginal Canadians.. PubMed. 12(1). 81–5. 12 indexed citations
13.
Wood, Mark, Juan Francisco Medina Gallardo, Glenn C. Thompson, J. C. Houck, & Kyung Wan Min. (1994). Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia. Otolaryngology. 111(6). 758–763. 24 indexed citations
14.
Jeffreys, R. V. & Mark Wood. (1978). Adult non-tumourous dementia and hydrocephalus. Acta Neurochirurgica. 45(1-2). 103–114. 6 indexed citations
15.
Stewart, C.J., et al.. (1973). Is tuberculin testing a necessary preliminary to BCG vaccination in Great Britain?. Tubercle. 54(3). 195–200. 1 indexed citations
16.
Wood, Mark, et al.. (1960). PROPHYLACTIC ISONIAZID IN NURSES IN A TUBERCULOSIS HOSPITAL. The Lancet. 276(7155). 837–840. 3 indexed citations
17.
Wood, Mark. (1955). Central nervous system complications during I.N.H. treatment of pulmonary tuberculosis. British Journal of Tuberculosis and Diseases of the Chest. 49(1). 20–29. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca Nicolai Breakdown of academic impact, for papers by S. Sen Breakdown of academic impact, for papers by Ali Karakuzu Breakdown of academic impact, for papers by Sara Taha Breakdown of academic impact, for papers by Ana Pérez Breakdown of academic impact, for papers by Emel Çalıkoğlu Breakdown of academic impact, for papers by Paula Boggio Breakdown of academic impact, for papers by António Panarra Breakdown of academic impact, for papers by Nordau Kanigsberg Breakdown of academic impact, for papers by Rohini Samant
Rankless by CCL
2026